Evidence map›Paper›PMID 12529391›Full record

ArticleMolecular and cellular biology2003

Protein kinase C phosphorylates ribosomal protein S6 kinase betaII and regulates its subcellular localization.

Taras Valovka, Frederique Verdier, Rainer Cramer, Alexander Zhyvoloup, Timothy Fenton, Heike Rebholz, Mong-Lien Wang, Miechyslav Gzhegotsky, Alexander Lutsyk, Genadiy Matsuka and 5 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer.International journal of molecular sciences · 2020
    Review
  11. Article
  12. Review
  13. Review
  14. Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  15. Article
  16. Article
  17. Review
  18. Time-varying causal inference from phosphoproteomic measurements in macrophage cells.IEEE transactions on biomedical circuits and systems · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Taras ValovkaLudwig Institute for Cancer Research, London W1W 7BS, United Kingdom.
Frederique Verdier
Rainer Cramer
Alexander Zhyvoloup
Timothy Fenton
Heike Rebholz
Mong-Lien Wang
Miechyslav Gzhegotsky
Alexander Lutsyk
Genadiy Matsuka
Valeriy Filonenko
Lijun Wang
Christopher G Proud
Peter J Parker
Ivan T Gout
Ludwig Cancer Research · BEUniversity College London · GBUniversity of Dundee · GBCancer Research UK · GBInstitute of Molecular Biology and Genetics · UAInstituto de Biomedicina y Genética Molecular de Valladolid · ES

Funding

Wellcome Trust
6 · The paper itself

Abstract

The ribosomal protein S6 kinase (S6K) belongs to the AGC family of Ser/Thr kinases and is known to be involved in the regulation of protein synthesis and the G(1)/S transition of the cell cycle. There are two forms of S6K, termed S6Kalpha and S6Kbeta, which have cytoplasmic and nuclear splice variants. Nucleocytoplasmic shuttling has been recently proposed for S6Kalpha, based on the use of the nuclear export inhibitor, leptomycin B. However, the molecular mechanisms regulating subcellular localization of S6Ks in response to mitogenic stimuli remain to be elucidated. Here we present data on the in vitro and in vivo phosphorylation of S6Kbeta, but not S6Kalpha, by protein kinase C (PKC). The site of phosphorylation was identified as S486, which is located within the C-terminal nuclear localization signal. Mutational analysis and the use of phosphospecific antibodies provided evidence that PKC-mediated phosphorylation at S486 does not affect S6K activity but eliminates the function of its nuclear localization signal and causes retention of an activated form of the kinase in the cytoplasm. Taken together, this study uncovers a novel mechanism for the regulation of nucleocytoplasmic shuttling of S6KbetaII by PKC-mediated phosphorylation.

Indexed as

Active Transport, Cell NucleusAmino Acid SequenceBinding SitesCell LineFatty Acids, UnsaturatedHumansInsulinIn Vitro TechniquesIsoenzymesMitogensMolecular Sequence DataPhenylephrinePhosphorylationProtein Kinase CRecombinant ProteinsRibosomal Protein S6 Kinases, 70-kDaFatty Acids, UnsaturatedInsulinIsoenzymesleptomycin BMitogensPhenylephrineProtein Kinase CRecombinant Proteinsribosomal protein S6 kinase, 70kD, polypeptide 2Ribosomal Protein S6 Kinases, 70-kDaTetradecanoylphorbol Acetate

Identifiers

PMID12529391
PMCPMC140705
OpenAlexW2099442582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.